Table 1.

Assignment of the structures of lipopeptides by LC–ESI–MS/MS in this study

Peak	Mass (M/S)	Rt (min)	Family	Assignment	Sequence
1	994	6.50	Surfactin	C12[M + H]+
2	1008	6.98		C13[M + H]+
3	1022	8.05		C14[M + H]+
4	1036	9.12		C15[M + H]+
5	1050	9.38		C16[M + H]+
6	994	6.38		C12[M + H]+
7	1008	6.94		C13[M + H]+
8	1022	8.17		C14[M + H]+
9	1036	8.63		C15[M + H]+
10	1050	9.63		C16[M + H]+
11	994	6.42		C12[M + H]+
12	1008	6.89		C13[M + H]+
13	1022	8.11		C14[M + H]+
14	1036	8.69		C15[M + H]+
16	1008	8.40		C14[M + H]+
17	1022	9.35		C15[M + H]+
18	1008	8.46		C14[M + H]+
19	1022	9.22		C15[M + H]+
20	1008	8.40	Surfactin	C14[M + H]+
21	1022	9.16		C15[M + H]+
22	1008	6.89		C12[M + H]+
23	1050	4.68	Esperin	C16[M + H]+
24	1050	5.12		C16[M + H]+
25	1012	4.81	Surfactin	Linear C12[M + H]+
26	1026	5.26		Linear C13[M + H]+
27	1040	5.87		Linear C14[M + H]+
28	1054	6.39		Linear C15[M + H]+
29	1068	7.17		Linear C16[M + H]+
30	1026	5.53	Surfactin	Linear C14[M + H]+
31	1031	6.98	Bacillomycin D	C14[M + H]+
32	1045	7.95		C15[M + H]+
33	1451	10.94	Fengycin A	C15[M + H]+
34	1465	10.82		C16[M + H]+
35	1479	12.63		C17[M + H]+
36	740	12.69		C17[M + 2H]2+
37	1493	13.01		C18[M + H]+
38	747	15.09		C18[M + 2H]2+
39	1479	12.71	Fengycin B	C15[M + H]+
40	740	12.61		C15[M + 2H]2+
41	1493	12.92		C16[M + H]+
42	747	13.15		C16[M + 2H]2+
43	1467	8.66	Fengycin A	Linear C15[M + H]+
44	1481	8.83		Linear C16[M + H]+
45	1495	12.36		Linear C17[M + H]+
46	1495	12.36	Fengycin B	Linear C15[M + H]+
47	1509	13.87		Linear C16[M + H]+